Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -180,966 | -147,644 | -97,389 | -50,379 | -102,680 |
| Depreciation Amortization | 2,761 | 2,030 | 1,264 | 688 | 1,371 |
| Accounts receivable | -15,415 | -9,815 | -4,418 | -1,187 | -650 |
| Other Working Capital | -21,633 | -19,827 | -8,065 | -9,288 | 4,520 |
| Other Operating Activity | 57,561 | 43,486 | 17,088 | 6,625 | 27,581 |
| Operating Cash Flow | $-157,692 | $-131,770 | $-91,520 | $-53,541 | $-69,858 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -150,843 |
| PPE Investments | -303 | -268 | -364 | -142 | -5,584 |
| Purchase Of Investment | 354,427 | -342,831 | -216,987 | -115,168 | N/A |
| Sale Of Investment | -438,958 | 263,752 | 164,651 | 60,940 | N/A |
| Other Investing Activity | -19,036 | -19,036 | -12,877 | -12,877 | -1,759 |
| Investing Cash Flow | $-103,870 | $-98,383 | $-65,577 | $-67,247 | $-158,186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 221,112 | 15,390 | 6,308 | 5,029 | 194,375 |
| Financing Cash Flow | $221,112 | $15,390 | $6,308 | $5,029 | $194,375 |
| Beginning Cash Position | 272,350 | 272,350 | 272,350 | 272,350 | 306,019 |
| End Cash Position | 231,900 | 57,587 | 121,561 | 156,591 | 272,350 |
| Net Cash Flow | $-40,450 | $-214,763 | $-150,789 | $-115,759 | $-33,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,692 | -131,770 | -91,520 | -53,541 | -69,858 |
| Capital Expenditure | -303 | -268 | -364 | -142 | -5,584 |
| Free Cash Flow | -157,995 | -132,038 | -91,884 | -53,683 | -75,442 |